|  | | Pharmacy Law Fast Facts |  | Pharmacists are often required or permitted to substitute a generic product for a prescribed trade name product. When substitution is done, pharmacists should assure that the prescribed and substituted products are bioequivalent. | |
|  | How the IRB and other sources of authority protect human beings from abuse by scientists. | |
|  | Standards for using drugs in ways that do not reflect information in the package insert. | |
|  | A description of what and how pharmacists are required to tell patients information about drugs. | |
|  | Guidelines for informing the FDA after the discovery of problems with drug use. | |
|
|
 |
Copyright © 2012 RxLaw.org. All rights reserved. *NAPLEX and MPJE are federally registered trademarks owned by the National Association of Boards of Pharmacy (NABP) and the pharmacy law review materials advertised by RxLaw.org herein are in no way authorized or sponsored by NABP. | Terms and Conditions
|
Privacy Policy |
 |